MedTrace Logo

Chemotherapy Induced Peripheral Neuropathy. Could Physical Therapy Help Treat Symptoms?

NCT02239601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2019-10-09

Study results available
· View outcomes & findings →

Summary

The cause of Chemotherapy-Induced Peripheral Neuropathy (CIPN) is still unknown. An estimated 55-60% of patients will experience lasting symptoms affecting function for years post-treatment. Physical therapy is an established, effective treatment for entrapped nerves and neuropathic pain. This study sought to identify additional risk factors and provide evidence for the role of physical therapy in the treatment of CIPN.

Conditions

  • Breast Cancer
  • Peripheral Neuropathy, Secondary to Drugs or Chemicals

Interventions

OTHER

Physical Therapy

Physical therapy assessment and treatment for any positive signs of nerve entrapment prior to chemotherapy including nerve gliding exercises, education and splinting. A home program was provided and continued throughout chemotherapy treatment

Sponsors & Collaborators

  • University of Manitoba

    collaborator OTHER

  • CancerCare Manitoba

    lead OTHER

Principal Investigators

  • Barbara L Shay, PhD · University of Manitoba

  • Elizabeth R Hammond, PhD · University of Manitoba

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-01
Primary Completion
2017-11-01
Completion
2017-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02239601 on ClinicalTrials.gov